Compare Revvity Inc (RVTY) vs AT&T Inc. (T) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs AT&T Inc. — how do they compare? Revvity Inc trades at $154.18 (market cap $16.98B), while AT&T Inc. trades at $22.18 (market cap $170.42B). The key difference: AT&T Inc. is far larger — about 10× Revvity Inc's market cap, and AT&T Inc. pays the higher dividend (4.46%). Which is the better fit depends on your goals — on Pluang, investors hold Revvity Inc for 12 Days and AT&T Inc. for 118 Days on average.
| RVTY | T | |
|---|---|---|
Market Cap | $16.98B | $170.42B |
Volume | 1,456,900 | 50,780,036 |
Sector | Health | Media |
52-Week High | $157.36 | $29.10 |
52-Week Low | $82.26 | $20.49 |
Typical Hold Time | 12 Days | 118 Days |
Enterprise Value | $19.30B | $315.74B |
Dividend Yield | 0.18% | 4.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $152.16, down 0.94% on the day, but maintains a bullish technical trend with strong moving average signals and support near $149. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results expected soon. Revenue remains stable around $2.9 billion, though net income margins have softened slightly. Recent news highlights product launches and strategic acquisitions, such as the Human Cell Design deal, to bolster its life sciences portfolio.
The outlook is supported by analyst optimism with a 51.72% buy rating and a consensus price target of $132.13, though the current price trades above this target. Key risks include premium valuation metrics, margin pressures, and exposure to macroeconomic headwinds. The stock's proximity to its 52-week high suggests momentum but warrants caution given rich multiples.
AT&T (T) trades at $24.885, up 1.68% today, with a bullish technical signal overall despite mixed moving averages and oscillators. The company shows strong fundamentals with a P/E of 8.21, net income margin of 16.94%, and consistent earnings beats in recent quarters. Recent news highlights a $3 billion fiber deal with Corning and a joint venture with T-Mobile and Verizon to expand coverage.
The outlook is positive with a consensus price target of $27.50, offering potential upside. Key risks include high debt levels and competitive pressures. The stock presents a value opportunity with a solid dividend, but investors should monitor debt management and revenue growth sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About AT&T Inc.
AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.
Read more on T →
